selected scholarly activity
-
books
-
chapters
- Antibiotics for asymptomatic bacteriuria in pregnancy.. Clinical Respiratory Journal. CD000490. 2001
-
conferences
- Pathogen inactivation: making decisions about new technologies. Transfusion. 2338-2347. 2007
- Antiretroviral exposure and carotid intimal medial thickness in a multicentre Canadian HIV cohort. Antiviral Therapy. L68-L69. 2004
- A multi-laboratory comparison of proficiency in testing susceptibility of Helicobacter pylori, and correlation between agar dilution and E test methods. Gut. A85-A85. 2001
- Laboratory proficiency in susceptibility testing of Helicobacter pylori using Agar Dilution and E test methods.. Gastroenterology. A586-A587. 2001
- METAANALYSIS OF IMMUNE GLOBULIN PROPHYLAXIS IN TRANSPLANT RECIPIENTS FOR THE PREVENTION OF SYMPTOMATIC CYTOMEGALOVIRUS DISEASE. Transplantation Proceedings. 1408-1410. 1993
-
journal articles
- Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial.. Nature Communications. 16:6000. 2025
- AeroVax: study protocol for a randomised, double-blind, placebo-controlled, phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humans.. ERJ Open Research. 11:758-2024. 2025
- Feasibility, safety and tolerability of estrogen and/or probiotics for improving vaginal health in Canadian African, Caribbean, and Black women: A pilot phase 1 clinical trial.. PLoS ONE. 20:e0315576. 2025
- Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials. The Lancet HIV. 11:e75-e85. 2024
- Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antiretroviral Therapies: A Systematic Review. Clinical Infectious Diseases. 77:1023-1031. 2023
- The knowledge-informed development of inhaled aerosol vaccine strategies. University of Toronto Medical Journal. 100:27-28. 2023
- SARS-CoV-2 Outbreak Investigation Using Contact Tracing and Whole-Genome Sequencing in an Ontario Tertiary Care Hospital. Microbiology spectrum. 11:e0190022. 2023
- BEING: Bone Health in Aging Women with HIV: Impact of Switching Antiretroviral Therapy on Bone Mineral Density During the Perimenopausal Period. AIDS Research and Human Retroviruses. 39:204-210. 2023
- Influence of previous experience with and beliefs regarding anal cancer screening on willingness to be screened among men living with HIV. BMC International Health and Human Rights. 22:2444. 2022
- Novel care pathway to optimise antimicrobial prescribing for uncomplicated community-acquired pneumonia: study protocol for a prospective before–after cohort study in the emergency department of a tertiary care Canadian children’s hospital. BMJ Open. 12:e062360-e062360. 2022
- Factors partitioning physical frailty in people aging with HIV: A classification and regression tree approach. HIV Medicine. 23:738-749. 2022
- Vaginal microbiota associated with oncogenic HPV in a cohort of HPV-vaccinated women living with HIV. International Journal of STD and AIDS. 33:847-855. 2022
- A longitudinal view of successful aging with HIV: role of resilience and environmental factors. Quality of Life Research. 31:1135-1145. 2022
- Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell. 185:896-915.e19. 2022
- Virologic failure in people living with HIV in 1st line ART: A 10-year Mexican population-based study. International Journal of STD and AIDS. 33:363-373. 2022
- Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans. JCI insight. 7:e155655. 2022
- A practical clinical guide to counselling on and managing contraception, pre-conception planning, and menopause for women living with HIV. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 6:278-295. 2021
- Patient characteristics and determinants of CD4 at diagnosis of HIV in Mexico from 2008 to 2017: a 10-year population-based study. AIDS Research and Therapy. 18:84. 2021
-
Hepatitis C virus testing in a clinical
HIV cohort in Ontario, Canada, 2000 to 2015. Health Science Reports. 4:e358. 2021 - Single-centre, open-label, randomised, trial to compare rapid molecular point-of-care streptococcal testing to standard laboratory-based testing for the management of streptococcal pharyngitis in children: study protocol. BMJ Open. 11:e047271-e047271. 2021
- Urinary symptoms and quality of life in women living with HIV: a cross-sectional study. International Urogynecology Journal and Pelvic Floor Dysfunction. 32:353-358. 2021
- The impact of routine HIV drug resistance testing in Ontario: A controlled interrupted time series study. PLoS ONE. 16:e0246766-e0246766. 2021
- Sexual Anxiety Among Women Living with HIV in the Era of Antiretroviral Treatment Suppressing HIV Transmission. Sexuality Research and Social Policy: Journal of NSRC. 17:765-779. 2020
- Immunological considerations for COVID-19 vaccine strategies. Nature Reviews Immunology. 20:615-632. 2020
- Impact of Loneliness on Brain Health and Quality of Life Among Adults Living With HIV in Canada. Journal of Acquired Immune Deficiency Syndromes (1999). 84:336-344. 2020
- Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccination. International Journal of Gynecology and Obstetrics. 150:108-115. 2020
- Brief Report: Persistence of Non-Vaccine Oncogenic HPV Genotypes in Quadrivalent HPV-Vaccinated Women Living With HIV. Journal of Acquired Immune Deficiency Syndromes (1999). 83:230-234. 2020
- Impact of quadrivalent HPV vaccine dose spacing on immunologic response in women living with HIV. Vaccine. 38:3073-3078. 2020
- Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial. The Lancet HIV. 7:e16-e26. 2020
- Relationships between cognition, function, and quality of life among HIV+ Canadian men. Quality of Life Research. 29:37-55. 2020
- A Latent Class Analysis of the Social Determinants of Health Impacting Heavy Alcohol Consumption Among Women Living with HIV in Canada: The Canadian HIV Women’s Sexual and Reproductive Health Cohort Study. AIDS and Behavior. 23:3226-3236. 2019
- Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database of Systematic Reviews. 2019. 2019
- A longitudinal study of associations between HIV‐related stigma, recent violence and depression among women living with HIV in a Canadian cohort study. Journal of the International AIDS Society. 22:e25341. 2019
- Relationships between Atherosclerosis and Plasma Antioxidant Micronutrients or Red Blood Cell Polyunsaturated Fatty Acids in People Living with HIV. Nutrients. 11:1292-1292. 2019
- The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living With Human Immunodeficiency Virus. Clinical Infectious Diseases. 68:788-794. 2019
- Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in Girls Living With HIV. Pediatric Infectious Disease Journal. 37:595-597. 2018
- Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial. The Lancet HIV. 5:e211-e220. 2018
- New Tuberculosis Vaccine Strategies: Taking Aim at Un-Natural Immunity. Trends in Immunology. 39:419-433. 2018
- Factors Associated With 30-Day Mortality Rate in Respiratory Infections Caused by Streptococcus pneumoniae. Clinical Infectious Diseases. 66:1282-1285. 2018
- Vitamin D and progression of carotid intima‐media thickness in HIV‐positive Canadians. HIV Medicine. 19:143-151. 2018
- Envisioning Women-Centered HIV Care: Perspectives from Women Living with HIV in Canada. Women's Health Issues. 27:721-730. 2017
- Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial. The Lancet HIV. 4:e486-e494. 2017
- Exploring the Factors Considered by People Living with HIV and Their Partners during Preconception. Journal of the International Association of Providers of AIDS Care. 16:239-246. 2017
- Induction of an Immune-Protective T-Cell Repertoire With Diverse Genetic Coverage by a Novel Viral-Vectored Tuberculosis Vaccine in Humans. Journal of Infectious Diseases. 214:1996-2005. 2016
- Establishing the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study (CHIWOS): Operationalizing Community-based Research in a Large National Quantitative Study. BMC Medical Research Methodology. 16:101. 2016
- HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine. Vaccine. 34:4799-4806. 2016
- Association of serotype with respiratory presentations of pneumococcal infection, Ontario, Canada, 2003–2011. Vaccine. 34:846-853. 2016
- Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs. Clinical Infectious Diseases. 62:139-147. 2016
- In HIV-1, immediate vs deferred antiretroviral therapy and isoniazid vs no isoniazid reduced severe illness at 30 mo. ACP journal club. 163:JC5-JC5. 2015
- In early HIV infection, immediate vs deferred antiretroviral therapy reduced serious illnesses at 3 years. ACP journal club. 163:JC4-JC4. 2015
- Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database of Systematic Reviews. 2015:CD000490. 2015
- Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database of Systematic Reviews. 2014:CD007482. 2014
- Previous Antibiotic Exposure and Antimicrobial Resistance in Invasive Pneumococcal Disease: Results From Prospective Surveillance. Clinical Infectious Diseases. 59:944-952. 2014
- New Approaches to TB Vaccination. Chest. 146:804-812. 2014
- Self-Reported Preconception Care of HIV-Positive Women of Reproductive Potential. Journal of the International Association of Providers of AIDS Care. 13:424-433. 2014
- Human type 5 adenovirus-based tuberculosis vaccine: is the respiratory route of delivery the future?. Expert Review of Vaccines. 13:927-930. 2014
- The importance of motherhood in HIV-positive women of reproductive age in Ontario, Canada. AIDS Care. 26:777-784. 2014
- Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study. BMC Infectious Diseases. 13:256. 2013
- Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995–2011. Vaccine. 31:5863-5871. 2013
- A Human Type 5 Adenovirus–Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity. Science Translational Medicine. 5:205ra134. 2013
- Evaluation of HIV and Highly Active Antiretroviral Therapy on the Natural History of Human Papillomavirus Infection and Cervical Cytopathologic Findings in HIV-Positive and High-Risk HIV-Negative Women. Journal of Infectious Diseases. 208:454-462. 2013
- Herpes Simplex Virus Type 2 Coinfection Does Not Accelerate CD4 Count Decline in Untreated HIV Infection. Clinical Infectious Diseases. 57:448-457. 2013
- Antivirals for influenza: a summary of a systematic review and meta-analysis of observational studies. Influenza and other Respiratory Viruses. 7:76-81. 2013
- High prevalence of unintended pregnancies in HIV‐positive women of reproductive age in Ontario, Canada: a retrospective study. HIV Medicine. 13:107-117. 2012
- Antibiotic prophylaxis regimens and drugs for cesarean section. Cochrane Database of Systematic Reviews. 2012:CD001136. 2012
- Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. ACP journal club. 156:512-524. 2012
- Safety and Tolerability of Varenicline Tartrate (Champix®/Chantix®) for Smoking Cessation in HIV-Infected Subjects: A Pilot Open-Label Study. AIDS Patient Care and STDs. 26:12-19. 2012
- A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune. AIDS. 25:731-739. 2011
- A comparison of the MOS-HIV and SF-12v2 for measuring health-related quality of life of men and women living with HIV/AIDS. AIDS Research and Therapy. 8:5-5. 2011
- Antibiotic prophylaxis for cesarean section. Cochrane Database of Systematic Reviews. 2010:CD000933. 2010
- Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Clinical Respiratory Journal. CD007482. 2010
- Intrapartum antibiotics for Group B streptococcal colonisation. Cochrane Database of Systematic Reviews. 2010:CD000115. 2010
- Effect of smoking on lung function, respiratory symptoms and respiratory diseases amongst HIV-positive subjects: a cross-sectional study. AIDS Research and Therapy. 7:6-6. 2010
- Preface to the first edition. Evidence Based Infectious Diseases. ix. 2009
- Preface to the second edition. Evidence Based Infectious Diseases. xi. 2009
- Fertility Desires and Intentions of HIV-Positive Women of Reproductive Age in Ontario, Canada: A Cross-Sectional Study. PLoS ONE. 4:e7925-e7925. 2009
- Population-Based Surveillance for Invasive Pneumococcal Disease in Homeless Adults in Toronto. PLoS ONE. 4:e7255-e7255. 2009
- Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV‐infected, therapy‐naïve patients: results of the EPIC study (CCR100136)*. HIV Medicine. 10:116-124. 2009
- Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study. AIDS Research and Therapy. 6:11-11. 2009
- Editorial comment. International Braz J Urol: official journal of the Brazilian Society of Urology. 34:705. 2008
- Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Clinical Respiratory Journal. 2008
- A Prospective Study of Body Fat Redistribution, Lipid, and Glucose Parameters in HIV-Infected Patients Initiating Combination Antiretroviral Therapy. HIV Research and Clinical Practice. 9:314-323. 2008
- Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. European Journal of Clinical Investigation. 38:50-57. 2008
- Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease. Clinical and Experimental Immunology. 97:68-75. 2008
- Lysis of CD4+ lymphocytes by non-HLA-restricted cytotoxic T lymphoe from HIV-infected individuals. Clinical and Experimental Immunology. 93:356-362. 2008
- Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD–ACE2 receptor interaction. Journal of General Virology. 89:1015-1024. 2008
- A large prospective study assessing injection site reactions, quality of life and preference in patients using the Biojector® vs standard needles for enfuvirtide administration*. HIV Medicine. 8:427-432. 2007
- Randomized Controlled Trial of Once-Daily Tenofovir, Lamivudine, and Lopinavir/Ritonavir Versus Remaining on the Same Regimen in Virologically Suppressed HIV-Infected Patients on Their First PI-Containing HAART Regimen. HIV Research and Clinical Practice. 8:259-268. 2007
- Pathogen inactivation: making decisions about new technologies – preliminary report of a consensus conference. Vox Sanguinis. 93:179-182. 2007
- Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtide☆. Antiviral Research. 75:58-63. 2007
- Asymptomatic bacteriuria in pregnancy. Best Practice and Research in Clinical Obstetrics and Gynaecology. 21:439-450. 2007
- Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co‐infection: Clinically relevant or a diagnostic problem?. Journal of Medical Virology. 79:694-700. 2007
- Invasive Pneumococcal Disease in Solid Organ Transplant Recipients—10-Year Prospective Population Surveillance. American Journal of Transplantation. 7:1209-1214. 2007
- Antibiotics for asymptomatic bacteriuria in pregnancy. Clinical Respiratory Journal. CD000490. 2007
- Identification badges: a potential fomite?. The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections / Association pour la prevention des infections a l'hopit. 22:162-166. 2007
- Polymorphism of the L1 Capsid Gene and Persistence of Human Papillomavirus Type 52 Infection in Women at High Risk or Infected by HIV. Journal of Acquired Immune Deficiency Syndromes (1999). 44:61-65. 2007
- A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome. European Journal of Clinical Nutrition. 60:1266-1276. 2006
- Prospective, Randomized Inpatient Study of Oral Metronidazole versus Oral Metronidazole and Rifampin for Treatment of Primary Episode ofClostridium difficile–Associated Diarrhea. Clinical Infectious Diseases. 43:547-552. 2006
- Enhanced Detection and Typing of Human Papillomavirus (HPV) DNA in Anogenital Samples with PGMY Primers and the Linear Array HPV Genotyping Test. Journal of Clinical Microbiology. 44:1998-2006. 2006
- Canadian Consensus Recommendations for the Optimal Use of Enfuvirtide in HIV/AIDS Patients. Canadian Journal of Infectious Diseases and Medical Microbiology. 17:155-163. 2006
- High Level of Correlation of Human Papillomavirus-16 DNA Viral Load Estimates Generated by Three Real-time PCR Assays Applied on Genital Specimens. Cancer Epidemiology, Biomarkers and Prevention. 14:2200-2207. 2005
- Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV‐seropositive and HIV‐seronegative women at risk for HIV infection. Journal of Medical Virology. 75:213-221. 2005
- Canadian Helicobacter Study Group Consensus Conference: Update on the Approach to Helicobacter Pylori Infection in Children and Adolescents – an Evidence-Based Evaluation. Canadian Journal of Gastroenterology and Hepatology. 19:399-408. 2005
- Outbreaks of Infection Caused by Community‐Acquired Methicillin‐Resistant Staphylococcus aureus in a Canadian Correctional Facility. Canadian Journal of Infectious Diseases and Medical Microbiology. 16:343-348. 2005
- Antibiotic regimens for endometritis after delivery. Clinical Respiratory Journal. CD001067. 2004
- Identification of Mutations in Proviral Long Terminal Repeats of HIV Type 1-Infected Subjects Naive to Drug Therapy. AIDS Research and Human Retroviruses. 20:1019-1021. 2004
- Cardiobacterium hominis endocarditis associated with very severe thrombocytopenia and platelet autoantibodies. American Journal of Hematology. 76:373-377. 2004
- Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine. Current Medical Research and Opinion. 20:1115-1123. 2004
- Triple nucleoside treatment with abacavir plus the lamivudine/ zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: results of a 48-week open-label, equivalence trial (CNA3014). Current Medical Research and Opinion. 20:1103-1114. 2004
- Short report: Ceftriaxone for cat and dog bites. Simple outpatient treatment.. Canadian Family Physician. 50:577-579. 2004
- Canadian Helicobacter Study Group Consensus Conference: Update on the Management ofHelicobacter pylori- An Evidence-Based Evaluation of Six Topics Relevant to Clinical Outcomes in Patients Evaluated forH pyloriInfection. Canadian Journal of Gastroenterology and Hepatology. 18:547-554. 2004
- Prevalence of selective inhibition of HPV‐16 DNA amplification in cervicovaginal lavages. Journal of Medical Virology. 72:132-137. 2004
- Real-time PCR assays using internal controls for quantitation of HPV-16 and β-globin DNA in cervicovaginal lavages. Journal of Virological Methods. 114:135-144. 2003
- Multilaboratory Comparison of Proficiencies in Susceptibility Testing of Helicobacter pylori and Correlation between Agar Dilution and E Test Methods. Antimicrobial Agents and Chemotherapy. 47:3138-3144. 2003
- Canadian consensus guidelines for the care of HIV-positive pregnant women: putting recommendations into practice.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 168:1683-1688. 2003
- Canadian consensus guidelines for the management of pregnancy, labour and delivery and for postpartum care in HIV-positive pregnant women and their offspring (summary of 2002 guidelines).. CANADIAN MEDICAL ASSOCIATION JOURNAL. 168:1671-1674. 2003
- Successful Discontinuation of Therapy for Disseminated Mycobacterium avium Complex Infection after Effective Antiretroviral Therapy. ACP journal club. 137:734-734. 2002
- Activities of New Fluoroquinolones, Ketolides, and Other Antimicrobials against Blood Culture Isolates of Viridans Group Streptococci from across Canada, 2000. Antimicrobial Agents and Chemotherapy. 46:1553-1556. 2002
- Antibiotic regimens for endometritis after delivery. Cochrane Database of Systematic Reviews. CD001067. 2002
- Antibiotic regimens for management of intraamniotic infection. Cochrane Database of Systematic Reviews. 2014:CD003254. 2002
- Etiology of Dyspepsia: Implication for Empiric Therapy. Canadian Journal of Gastroenterology and Hepatology. 16:635-641. 2002
- Nonisotopic Detection of Human Papillomavirus DNA in Clinical Specimens Using a Consensus PCR and a Generic Probe Mix in an Enzyme-Linked Immunosorbent Assay Format. Journal of Clinical Microbiology. 39:3530-3536. 2001
- Intravenous and Oral Itraconazole versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial Therapy. ACP journal club. 135:412-412. 2001
- Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. Journal of Antimicrobial Chemotherapy. 46:1001-1008. 2000
- Etiology of community-acquired pediatric viral diarrhea: a prospective longitudinal study in hospitals, emergency departments, pediatric practices and child care centers during the winter rotavirus outbreak, 1997 to 1998. Pediatric Infectious Disease Journal. 19:843-848. 2000
- An Outbreak of Influenza A in a Neonatal Intensive Care Unit. Infection Control and Hospital Epidemiology. 21:449-454. 2000
- Factors Contributing to the Lack of Human Immunodeficiency Virus Type 1 (HIV‐1) Transmission in HIV‐1–Discordant Partners. Journal of Infectious Diseases. 182:123-132. 2000
- RANTES Production by T Cells and CD8‐Mediated Inhibition of Human Immunodeficiency Virus Gene Expression before Initiation of Potent Antiretroviral Therapy Predict Sustained Suppression of Viral Replication. Journal of Infectious Diseases. 181:505-512. 2000
- The anti‐idiotypic antibody 1F7 selectively inhibits cytotoxic T cells activated in HIV‐1 infection. Immunology and Cell Biology. 78:20-27. 2000
- Antibiotic Susceptibility and Resistance Testing: An Overview. Canadian Journal of Gastroenterology and Hepatology. 14:871-875. 2000
- Antibiotic regimens for endometritis after delivery.. Cochrane Database of Systematic Reviews. CD001067. 2000
- Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database of Systematic Reviews. CD000490. 2000
- Detection of Human Papillomavirus Type 16 DNA in Consecutive Genital Samples Does Not Always Represent Persistent Infection as Determined by Molecular Variant Analysis. Journal of Clinical Microbiology. 38:3388-3393. 2000
- Experience with a Special Outpatient Antimicrobial Program at McMaster University Medical Centre in 1997. Canadian Journal of Infectious Diseases and Medical Microbiology. 11:15a-16a. 2000
- Implications of Antibiotic Resistance in the Management ofHelicobacter pyloriInfection: CanadianHelicobacterStudy Group. Canadian Journal of Gastroenterology and Hepatology. 14:862-868. 2000
- Intrapartum antibiotics for Group B streptococcal colonisation. Cochrane Database of Systematic Reviews. CD000115. 2000
- Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database of Systematic Reviews. 1999:CD001363. 2000
- Review: Antibiotic prophylaxis reduces infectious complications in caesarean delivery. Evidence-Based Medicine. 4:179. 1999
- Replication-Defective Adenovirus Infection ReducesHelicobacter felisColonization in the Mouse in a Gamma Interferon- and Interleukin-12-Dependent Manner. Infection and Immunity. 67:4539-4544. 1999
- Review: 6- and 12-month courses of isoniazid prevent active tuberculosis in HIV-negative persons. Evidence-Based Medicine. 4:122. 1999
- Isoniazid for preventing tuberculosis in non-HIV infected persons. Praxis. 88:1092. 1999
- Nonisotopic Detection and Typing of Human Papillomavirus DNA in Genital Samples by the Line Blot Assay. Journal of Clinical Microbiology. 37:1852-1857. 1999
- Predictors of survival and eradication of Mycobacterium avium complex bacteremia (MAC) in AIDS patients in the Canadian Randomized MAC Treatment Trial. AIDS. 13:575-582. 1999
- Antimicrobial Regimens Prescribed by Canadian Physicians for Chemotherapy‐Induced Febrile Neutropenic Episodes. Canadian Journal of Infectious Diseases and Medical Microbiology. 10:353-357. 1999
- Incremental Cost-Effectiveness Analysis of Intravenous Ganciclovir Versus Oral Ganciclovir in the Maintenance Treatment of Newly Diagnosed Cytomegalovirus Retinitis in Patients with AIDS. PharmacoEconomics (Auckland). 16:71-84. 1999
- Recent advances: Medical microbiology. The BMJ. 317:1060-1062. 1998
- Recent advances: medical microbiology.. The BMJ. 317:1060-1062. 1998
- Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: Results of a Canadian collaborative study. Journal of Pediatrics. 132:777-782. 1998
- A Canadian hospital-based HIV/hepatitis C look-back notification program.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 157:149-154. 1997
- Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. European Journal of Clinical Microbiology and Infectious Diseases. 16:337-345. 1997
- CD8+ T cell-mediated suppression of HIV long terminal repeat-driven gene expression is not associated with improved clinical status. AIDS. 11:581-586. 1997
- A randomized trial of surgical scrubbing with a brush compared to antiseptic soap alone. American Journal of Infection Control. 25:11-15. 1997
- Evaluation of Salivary Antibodies to Detect Infection with Helicobacter pylori. Canadian Journal of Gastroenterology and Hepatology. 11:437-440. 1997
- Detection of a transforming fragment of herpes simplex virus type 2 in clinical specimens by PCR. The Canadian Women's HIV Study Group. Journal of Clinical Microbiology. 34:1654-1659. 1996
- Cytotoxic T-lymphocytes from HIV-infected individuals recognize an activation-dependent, non-polymorphic molecule on uninfected CD4+ lymphocytes. AIDS. 10:247-254. 1996
- Detection of Chlamydia trachomatis in Genitourinary Tract Specimens Using an Automated Enzyme-Linked Fluorescent Immunoassay. Sexually Transmitted Diseases. 23:115-119. 1996
- Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis.. Clinical Transplantation. 9:490-491. 1995
- Role of herpes simplex type 2 in genital cancers: Review of the evidence. Archives of STD/HIV Research. 9:163-179. 1995
- Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis.. Clinical Transplantation. 8:10-18. 1994
- Antibiotic prophylaxis and caesarean section. BJOG: An International Journal of Obstetrics and Gynaecology. 100:704-704. 1993
- Authors' reply. BJOG: An International Journal of Obstetrics and Gynaecology. 100:503-503. 1993
- Meta-analysis of immune globulin prophylaxis in transplant recipients for the prevention of symptomatic cytomegalovirus disease.. Transplantation Proceedings. 25:1408-1410. 1993
- Changes in the Cytotoxic T-Cell Repertoire of HIV-1-Infected Individuals: Relationship to Disease Progression. Viral Immunology. 6:85-95. 1993
- Antibiotic prophylaxis and caesarean section. BJOG: An International Journal of Obstetrics and Gynaecology. 99:789-790. 1992
- The influence of lymphocyte counts and disease progression on circulating and inducible anti-HIV-1 cytotoxic T-cell activity in HIV-1-infected subjects. AIDS. 6:1085-1094. 1992
- Genitourinary tract infections in pregnancy and low birth weight.. The BMJ. 304:54-55. 1992
- Combined testing for antibodies to rubella non-structural and envelope proteins sentinels infections in two outbreaks. Diagnostic Microbiology and Infectious Disease. 8:173-177. 1987
- Subclavian vein catheterisation for haemodialysis.. Proceedings of the University of Otago Medical School. 97:433-436. 1984